These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1193300)

  • 1. Corneal development. V. Treatment of five-day-old embryos of domestic fowl with 6-diazo-5-oxo-L-norleucine (DON).
    Coulombre J; Coulombre A
    Dev Biol; 1975 Aug; 45(2):291-303. PubMed ID: 1193300
    [No Abstract]   [Full Text] [Related]  

  • 2. Corneal geometry: an alternative explanation of the effect of 6-diazo-5-oxo-l-norleucine on the development of chick cornea.
    Gordon H
    Dev Biol; 1976 Oct; 53(2):303-5. PubMed ID: 992212
    [No Abstract]   [Full Text] [Related]  

  • 3. Avian corneal innervation: inhibition of nerve ring formation by 6-diazo-5-oxo-L-norleucine.
    Bee JA; Unruh NC; Sommerfeld DL; Conrad GW
    Dev Biol; 1982 Jul; 92(1):123-32. PubMed ID: 7106373
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of 6-diazo-5-oxo-L-norleucine to study interaction between myocardial glycoconjugate secretion and endothelial activation in the early embryonic chick heart.
    Markwald RR; Funderburg FM
    Dev Biol; 1983 Oct; 99(2):395-407. PubMed ID: 6618009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cartilage formation: effects of 6-diazo-5-oxo-L-norleucine (DON) on glycosaminoglycan and collagen synthesis.
    Linsenmayer TF; Kochhar DM
    Dev Biol; 1979 Apr; 69(2):517-28. PubMed ID: 437352
    [No Abstract]   [Full Text] [Related]  

  • 6. The rediscovery of DON (6-diazo-5-oxo-L-norleucine).
    Kisner DL; Catane R; Muggia FM
    Recent Results Cancer Res; 1980; 74():258-63. PubMed ID: 7192426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by diazo-oxo-norleucine (DON) of rat palatal glycoproteins synthesis and epithelial cell adhesion in vitro.
    Greene RM; Pratt RM
    Exp Cell Res; 1977 Mar; 105(1):27-37. PubMed ID: 837996
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of diazo-oxo-norleucine on cell kinetics and odontoblast differentiation in cultured embryonic mouse molars.
    Olive M; Ruch JV
    Arch Oral Biol; 1982; 27(6):505-11. PubMed ID: 6956264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
    Ovejera AA; Houchens DP; Catane R; Sheridan MA; Muggia FM
    Cancer Res; 1979 Aug; 39(8):3220-4. PubMed ID: 572261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and phase I study of intravenous DON (6-diazo-5-oxo-L-norleucine) in children.
    Sullivan MP; Nelson JA; Feldman S; Van Nguyen B
    Cancer Chemother Pharmacol; 1988; 21(1):78-84. PubMed ID: 3342470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inactivation of microbial glutamin-(asparagin-)ase by azaserine and 6-diazo-5-oxo-L-norleucine].
    Lebedeva ZI; Kabanova EA; Berezov TT
    Biull Eksp Biol Med; 1985 Dec; 100(12):696-8. PubMed ID: 4074870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of morphogenetic cell interactions by 6-diazo-5-oxo-norleucine (DON).
    Ekblom P; Lash JW; Lehtonen E; Nordling S; Saxén L
    Exp Cell Res; 1979 Jun; 121(1):121-6. PubMed ID: 446523
    [No Abstract]   [Full Text] [Related]  

  • 13. Diazo-oxo-norleucine (DON)-induced alterations in the extracellular matrix of the mouse tooth germ.
    Hurmerinta K; Thesleff I
    Cell Differ; 1982 Apr; 11(2):107-13. PubMed ID: 7066992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
    Willis RC; Seegmiller JE
    J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of 6-diazo-5-oxo-L-norleucine (DON), a glutamine analogue, on cartilaginous differentiation in mouse limb buds in vitro.
    Aydelotte MB; Kochhar DM
    Differentiation; 1975 Oct; 4(2):73-80. PubMed ID: 1183764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of 6-diazo-5-oxo-L-norleucine, a glutamine analogue, on the structure of the major cartilage proteoglycan synthesized by cultured chondrocytes.
    Clark CC; Richards CF; Pacifici M; Iozzo RV
    J Biol Chem; 1987 Jul; 262(21):10229-38. PubMed ID: 3112139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic inhibitors and glucose oxidation in developing chick cornea.
    Masterson E; O'Brien PJ; Chader GJ
    Exp Eye Res; 1979 Feb; 28(2):121-7. PubMed ID: 446556
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.
    Lynch G; Kemeny N; Casper E
    Am J Clin Oncol; 1982 Oct; 5(5):541-3. PubMed ID: 7180833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity of D- and L-azaserine, 6-diazo-5-oxo-L-norleucine and N-(N-methyl-N-nitroso-carbamyl)-L-ornithine in the Salmonella test system.
    Staiano N; Everson RB; Cooney DA; Longnecker DS; Thorgeirsson SS
    Mutat Res; 1980 Dec; 79(4):387-90. PubMed ID: 7003378
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I study of 6-diazo-5-oxo-L-norleucine (DON).
    Sklaroff RB; Casper ES; Magill GB; Young CW
    Cancer Treat Rep; 1980; 64(12):1247-51. PubMed ID: 7471114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.